http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100540021-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 |
| filingDate | 2001-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100540021-B1 |
| titleOfInvention | Erythromycin derivative having novel crystal structures and processes for their production |
| abstract | The present invention relates to N-demethyl-N-isopropyl-12-methoxy-11-oxo-anhydroerythromycin having a strong diffraction peak at diffraction angles (2θ) of 5.6 ° and 10.4 ° by powder X-ray diffraction. E form crystals of A-6,9-halfacetal fumaric acid salts, E form crystals prepared by treating C form crystals of fumaric acid salts of the compounds at 20 ° C. to 40 ° C. in a mixed solvent consisting of ethyl acetate and water, and E form crystals Provides Form D crystals that are made via light oil. The crystal contains little residual solvent and is suitable for pharmaceutical preparation. |
| priorityDate | 2000-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.